G protein-coupled receptor
5-HT2A receptor
5-hydroxytryptamine receptor 2A
- GeneHTR2A
- FamilySerotonin receptors
- Group5-HT2 receptors
The 5-HT2A receptor is one of the receptors for serotonin. It belongs to the G protein-coupled receptors, which have seven transmembrane domains and pass signals into the cell through G proteins. The human receptor was cloned from brain stem tissue, at the time under the name 5-HT2.1 Together with the 5-HT2B and 5-HT2C receptors it forms the 5-HT2 family. The three are similar in structure, pharmacology and signalling, and they are the only serotonin receptors that couple mainly to Gq.2,3
When an agonist binds, the receptor activates the G protein Gq. In the rat cortex, serotonin acting at this receptor stimulates the breakdown of membrane phosphoinositides.4,5 Gq activates phospholipase C, which forms inositol trisphosphate and diacylglycerol, mobilises calcium inside the cell and activates protein kinase C. The receptor also triggers arrestin signalling and the release of arachidonic acid. In many brain regions its activation excites neurons, probably by closing potassium channels. DOI, DOB, DOM and LSD behave as partial agonists in assays of the second messengers, and stimulation of the receptor changes the expression of several genes, among them the one for the neurotrophic factor BDNF.6,2,7 In cells that carry the human receptor, agonists cause a rapid rise in calcium inside the cell.8
The 5-HT2A receptor is the most abundant excitatory serotonin receptor in the brain, with the highest density in layer V of the cortex. It is also found in nearly every other tissue of the body to some degree.3 In the rat brain the mRNA of the receptor reaches high levels in only a few areas, among them the frontal cortex, the piriform cortex, the ventral and caudal part of area CA3, the medial mammillary nucleus, the pontine nuclei, the motor nuclei of the cranial nerves and the ventral horn of the spinal cord. It generally agrees with the distribution of the binding sites, although there are differences. The same study found no evidence of mRNA for the 5-HT2B receptor in the rat brain.9 In the cerebral cortex of the monkey and the rat, most cells that carry the receptor are pyramidal neurons. In the monkey the strongest labelling lies on their apical dendrites. Some interneurons carry the receptor too.10,11 Immunostaining, in situ hybridisation and autoradiography have so far found the receptor on neurons, although cultured astrocytes and glioma cells also express it. In the cortex it sits on local GABAergic interneurons and on glutamatergic pyramidal neurons, and it may also sit on cholinergic neurons of the basal forebrain. In the prefrontal cortex the receptors are mostly postsynaptic and are highly enriched on the apical dendrites of pyramidal neurons in the deep layers.2,7
PET scans of healthy volunteers have mapped the receptor in the living human brain. In the cortex its density follows the amount of its messenger RNA, in deeper regions it does not.12 In postmortem human brain, autoradiography with the antagonist M100907 showed very dense binding in all neocortical regions and only weak binding in the hippocampus. The basal ganglia and thalamus had low binding, and the cerebellum and the brainstem were virtually free of the receptor. Ketanserin and SCH 23390 displaced the radioligand, while the 5-HT1A antagonist WAY-100635 and the D2 antagonist raclopride did not.13
The receptor of rodents differs from that of humans at one position of the binding pocket. Primate and pig receptors have a serine at residue 242, rat and mouse receptors an alanine. This single change is largely responsible for marked pharmacological differences between the mouse and the human receptor, although the receptors of mammals are about 90 percent alike overall.3,7
Mice in which signalling through the receptor is disrupted show less inhibition in several tests of conflict anxiety, while their fear learning and their behaviour in tests of depression are not changed. Putting the receptor back only in the forebrain restored it mainly in layer V of the cortex and normalised the behaviour. This points to the cortex as the site of the effect.14
Psychedelics such as LSD, psilocybin and DMT are agonists at the 5-HT2A receptor, and the receptor is regarded as their primary target. Receptor occupancy in the brain relates closely to the intensity of the psychedelic effect in humans, and hallucinogenic potencies in humans and in rodent drug discrimination tests scale with the affinity for the receptor. The head-twitch response of mice, whose potencies correlate strongly with human hallucinogenic potencies, is abolished in knockout mice. A recent review reports lasting effects of psilocybin, DMT and LSD in clinical trials for major depression and substance use disorders.7,3
In a placebo-controlled study, ketanserin, which blocks 5-HT2A receptors, fully blocked the subjective effects of LSD.15 Ketanserin also blocked the effects of psilocybin, and did so in a dose-dependent way. A dose of 40 mg prevented them completely in four of five volunteers.16 Given together with mescaline, it strongly reduced the acute effects.17 Across fifteen hallucinogens, the potency in humans followed the affinity for cortical 5-HT2 binding sites.18
Blocking the receptor is a shared property of the atypical antipsychotics. Clozapine, olanzapine, quetiapine, risperidone, sertindole and ziprasidone are potent 5-HT2A antagonists and relatively weaker dopamine D2 antagonists, and at effective doses they share a low rate of extrapyramidal side effects. Meltzer put forward that a high affinity for 5-HT2A relative to D2 is what separates these atypical drugs from the typical ones.19 Trials of drugs that block only the 5-HT2A receptor gave limited evidence so far. Ritanserin, which also blocks the 5-HT2C receptor, brought little or no benefit, and M100907 showed some efficacy in one controlled study. A highly selective 5-HT2A inverse agonist, pimavanserin, has been approved for the treatment of psychosis in Parkinson's disease.19,3
Sources (19)
- Saltzman et al. 1991Saltzman AG, Morse B, Whitman MM, et al. (1991) Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes Biochem Biophys Res Commun
- Barnes et al. 1999Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function Neuropharmacology
- Cummins et al. 2025Cummins BR, Billac GB, Nichols DE, et al. (2025) 5-HT(2A) receptors: Pharmacology and functional selectivity Pharmacol Rev
- Kim et al. 2020Kim K, Che T, Panova O, et al. (2020) Structure of a Hallucinogen-Activated Gq-Coupled 5-HT(2A) Serotonin Receptor Cell
- Conn et al. 1986Conn PJ, Sanders-Bush E (1986) Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site J Neurosci
- Barnes et al. 2021Barnes NM, Ahern GP, Becamel C, et al. (2021) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function Pharmacol Rev
- Kwan et al. 2022Kwan AC, Olson DE, Preller KH, et al. (2022) The neural basis of psychedelic action Nature Neuroscience
- Porter et al. 1999Porter RH, Benwell KR, Lamb H, et al. (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells Br J Pharmacol
- Pompeiano et al. 1994Pompeiano M, Palacios JM, Mengod G (1994) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors Brain Res Mol Brain Res
- Jakab et al. 1998Jakab RL, Goldman-Rakic PS (1998) 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites Proc Natl Acad Sci U S A
- Willins et al. 1997Willins DL, Deutch AY, Roth BL (1997) Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex Synapse
- Beliveau et al. 2017Beliveau V, Ganz M, Feng L, et al. (2017) A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System J Neurosci
- Hall et al. 2000Hall H, Farde L, Halldin C, et al. (2000) Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907 Synapse
- Weisstaub et al. 2006Weisstaub NV, Zhou M, Lira A, et al. (2006) Cortical 5-HT <sub>2A</sub> Receptor Signaling Modulates Anxiety-Like Behaviors in Mice Science
- Preller et al. 2017Preller KH, Herdener M, Pokorny T, et al. (2017) The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation Curr Biol
- Vollenweider et al. 1998Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, et al. (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport
- Klaiber et al. 2024Klaiber A, Schmid Y, Becker AM, et al. (2024) Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects Transl Psychiatry
- Glennon et al. 1984Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents Life Sci
- Meltzer 1999Meltzer HY (1999) The role of serotonin in antipsychotic drug action Neuropsychopharmacology
Binding affinity (Kᵢ)
29 substances, 49 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.
Human
27 measurements
DOB0.60 nMNelson et al. 1999
- Assay
- cloned human 5-HT2A receptor in AV12 cells; agonist-radioligand [125I]DOI binding
- Shown value from
- Nelson et al. 1999, Table 1
- Error
- ± 0.10 SEM, n = 3
Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 0.60–23 nM.
DOI0.70 nMNelson et al. 1999 · 6 reports
- Assay
- cloned human 5-HT2A receptor in AV12 cells; agonist-radioligand [125I]DOI binding
- Shown value from
- Nelson et al. 1999, Table 1
- Range
- 0.70–2500 nM in 6 reports
- Error
- ± 0.06 SEM, n = 3
Values depend on the assay, species or conditions, and each is valid only for its own. 7 reports in all, 0.70–2500 nM.
Sources and values behind the range, same assay family Report Value Where Nelson et al. 1999 0.70 nM Table 1 Boess et al. 1994 1.6 nM, 38 nM, 2500 nM Table 8 Jain et al. 2025 19 nM Table S4 Glatfelter et al. 2022 11 nM Table 1 2C-B0.88 nMMcLean et al. 2006
- Assay
- cloned human 5-HT2A, agonist radioligand [125I]DOI
- Shown value from
- McLean et al. 2006, Table 1 (compound 1)
- Error
- ± 0.04 SEM
Values depend on the assay, species or conditions, and each is valid only for its own. 3 reports in all, 0.88–28 nM.
2C-I3.5 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A (functional FLIPR membrane potential)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 1.0 SD
2C-P8.1 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A (functional FLIPR membrane potential)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 1.0 SD
ETH-LAD9.3 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
2C-E11 nMRickli et al. 2015 · 2 reports
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Range
- 11–44 nM in 2 reports
- Error
- ± 1.0 SD
Values depend on the assay, species or conditions, and each is valid only for its own. 3 reports in all, 4.5–44 nM.
Sources and values behind the range, same assay family Report Value Where Ray 2010 44 nM Table S2 (AllKiData) Rickli et al. 2015 11 nM Table 1 2C-C13 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A (functional FLIPR membrane potential)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 5.0 SD
LSD15 nMHalberstadt et al. 2020 · 9 reports
- Assay
- cloned human 5-HT2A receptor; [3H]ketanserin competition
- Shown value from
- Halberstadt et al. 2020, Table 1
- Range
- 0.09–15 nM in 9 reports
- Error
- ± 4.2 SEM, n = 5
Values depend on the assay, species or conditions, and each is valid only for its own. 11 reports in all, 0.09–15 nM.
Sources and values behind the range, same assay family Report Value Where Halberstadt et al. 2020 15 nM Table 1 Jain et al. 2025 8.5 nM Table S4 Eshleman et al. 2018 0.09 nM Table 1 Janowsky et al. 2014 0.71 nM, 0.72 nM, 0.47 nM Table 1, Table 3 Eshleman et al. 2014 0.47 nM Table 2 Eshleman et al. 2013 0.15 nM Table 5 Almaula et al. 1996 0.38 nM Table I AL-LAD17 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
DOM18 nMEshleman et al. 2018 · 7 reports
- Assay
- recombinant human 5-HT2A receptor; [125I]DOI competition binding
- Shown value from
- Eshleman et al. 2018, Table 1
- Range
- 2.1–190 nM in 7 reports
- Error
- ± 1.7 SEM, n = 4
Values depend on the assay, species or conditions, and each is valid only for its own. 8 reports in all, 2.1–507 nM.
Sources and values behind the range, same assay family Report Value Where Luethi et al. 2026 66 nM Table 1 Eshleman et al. 2018 18 nM Table 1 Janowsky et al. 2014 4.3 nM, 2.1 nM, 14 nM Table 1, Table 3 Jain et al. 2025 190 nM Table S4 Eshleman et al. 2014 8.1 nM Table 2 2C-D32 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A (functional FLIPR membrane potential)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 5.0 SD
4-HO-MET46 nMKozell et al. 2023 · 3 reports
- Assay
- human 5-HT2A receptor in HEK-293 cells; [3H]5-HT competition binding
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 46–177 nM in 3 reports
- Error
- ± 4.9 SEM, n = 3
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 57 nM Table 1 Kozell et al. 2023 46 nM Table 1 Glatfelter et al. 2023 177 nM Table 2 5-MeO-DMT105 nMPuigseslloses et al. 2024 · 4 reports
- Assay
- human 5-HT2A receptor membranes; [3H]ketanserin competition binding
- Shown value from
- Puigseslloses et al. 2024, Table 1
- Range
- 105–907 nM in 4 reports
- Error
- ± 22 SD
This is the best-supported value. Other reports differ. 5 reports in all, 105–2011 nM.
Sources and values behind the range, same assay family Report Value Where Halberstadt et al. 2012 907 nM Table 1 Puigseslloses et al. 2024 105 nM Table 1 Jain et al. 2025 200 nM Table S4 Glatfelter et al. 2024 113 nM Supplement Figure S1 5-MeO-MiPT113 nMKozell et al. 2023 · 4 reports
- Assay
- human 5-HT2A receptor in HEK-293 cells; [3H]5-HT competition binding
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 113–215 nM in 4 reports
- Error
- ± 31 SEM, n = 4
This is the best-supported value. Other reports differ. 5 reports in all, 113–448 nM.
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 163 nM Table 1 Kozell et al. 2023 113 nM Table 1 Puigseslloses et al. 2024 147 nM Table 1 Glatfelter et al. 2024 215 nM Supplement Figure S1 Bufotenin162 nMAlmaula et al. 1996 · 2 reports
- Assay
- human 5-HT2A receptor in COS-1 cells, [3H]ketanserin competition
- Shown value from
- Almaula et al. 1996, Table I
- Range
- 162–220 nM in 2 reports
- Error
- ± 14 SEM, n = 4
Sources and values behind the range, same assay family Report Value Where Jain et al. 2025 220 nM Table S4 Almaula et al. 1996 162 nM Table I ALD-52174 nMHalberstadt et al. 2020
- Assay
- cloned human 5-HT2A receptor; [3H]ketanserin competition
- Shown value from
- Halberstadt et al. 2020, Table 1
- Error
- ± 43 SEM, n = 3
Psilocin200 nMJain et al. 2025 · 4 reports
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
- Range
- 49–200 nM in 4 reports
Reported values disagree and no value is established. 5 reports in all, 49–340 nM.
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 49 nM Table 1 Glatfelter et al. 2022 180 nM Table 1 Jain et al. 2025 200 nM Table S4 Dodd et al. 2023 49 nM Table 2 DMT347 nMKozell et al. 2023 · 7 reports
- Assay
- human 5-HT2A receptor in HEK-293 cells; [3H]5-HT competition binding
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 53–380 nM in 7 reports
- Error
- ± 47 SEM, n = 22
This is the best-supported value. Other reports differ. 8 reports in all, 53–2323 nM.
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 237 nM Table 1 Kozell et al. 2023 347 nM Table 1 Janowsky et al. 2014 210 nM, 53 nM, 175 nM Table 1, Table 3 Jain et al. 2025 380 nM Table S4 Eshleman et al. 2014 201 nM Table 2 5-APB840 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 270 SD
Psilocybin850 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
6-APB970 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 230 SD
MDA3300 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 800 SD
4-FMA3800 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 700 SEM
Mescaline6300 nMRickli et al. 2015
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 1800 SD
Reported values disagree and no value is established. 2 reports in all, 1900–6300 nM.
MDMA8300 nMEshleman et al. 2013 · 2 reports
- Assay
- cells expressing human 5-HT2A, [125I]DOI displacement
- Shown value from
- Eshleman et al. 2013, Table 5
- Range
- 7800–8300 nM in 2 reports
- Error
- ± 1200 SEM, n = 4
Sources and values behind the range, same assay family Report Value Where Simmler et al. 2013 7800 nM Table 1 Eshleman et al. 2013 8300 nM Table 5 Mephedrone9000 nMEshleman et al. 2013 · 2 reports
- Assay
- cells expressing human 5-HT2A, [125I]DOI displacement
- Shown value from
- Eshleman et al. 2013, Table 5
- Range
- 2100–9000 nM in 2 reports
- Error
- ± 1500 SEM, n = 4
Reported values disagree and no value is established. 2 reports in all, 2100–9000 nM.
Sources and values behind the range, same assay family Report Value Where Simmler et al. 2013 2100 nM Table 1 Eshleman et al. 2013 9000 nM Table 5
Mouse
4 measurements
5-MeO-MiPT209 nMGlatfelter et al. 2024
- Assay
- mouse brain membranes, [3H]M100907 competition binding at 5-HT2A
- Shown value from
- Glatfelter et al. 2024, Supplement Figure S12
5-MeO-DMT212 nMGlatfelter et al. 2024
- Assay
- mouse brain membranes, [3H]M100907 competition binding at 5-HT2A
- Shown value from
- Glatfelter et al. 2024, Supplement Figure S12
Psilocin235 nMGlatfelter et al. 2022
- Assay
- C57BL/6J mouse brain membranes; [3H]M100907 displacement
- Shown value from
- Glatfelter et al. 2022, Table 2
Psilocybin2096 nMGlatfelter et al. 2022
- Assay
- C57BL/6J mouse brain membranes; [3H]M100907 displacement
- Shown value from
- Glatfelter et al. 2022, Table 2
Rat
9 measurements
2C-B0.66 nMMcLean et al. 2006 · 2 reports
- Assay
- cloned rat 5-HT2A, agonist radioligand [125I]DOI
- Shown value from
- McLean et al. 2006, Table 1 (compound 1)
- Range
- 0.66–36 nM in 2 reports
- Error
- ± 0.12 SEM
Sources and values behind the range, same assay family Report Value Where McLean et al. 2006 0.66 nM Table 1 (compound 1) Halberstadt 2017 36 nM Review text, Structure-Activity Relationships (p. 3) ETH-LAD5.1 nMPfaff et al. 1994 · 2 reports
- Assay
- rat frontal cortex homogenate; [3H]ketanserin displacement
- Shown value from
- Pfaff et al. 1994, Table 1
AL-LAD8.1 nMPfaff et al. 1994 · 2 reports
- Assay
- rat frontal cortex homogenate; [3H]ketanserin displacement
- Shown value from
- Pfaff et al. 1994, Table 1
- Range
- 3.4–8.1 nM in 2 reports
Psilocin25 nMDodd et al. 2023 · 2 reports
- Assay
- 5-HT2A binding, compiled in a review (Table 2), original assay not restated
- Shown value from
- Dodd et al. 2023, Table 2
- Range
- 6.0–25 nM in 2 reports
Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 6.0–25 nM.
DOM100 nMSeggel et al. 1990 · 2 reports
- Assay
- Rat frontal cortex homogenate, [3H]ketanserin binding (5-HT2 receptor, now 5-HT2A)
- Shown value from
- Seggel et al. 1990, Table I
Sources and values behind the range, same assay family Report Value Where Seggel et al. 1990 100 nM Table I Halberstadt 2017 100 nM Review text, Structure-Activity Relationships (p. 3) 5-MeO-DMT390 nMGlennon et al. 1984 · 4 reports
- Assay
- rat cortical membranes, [3H]ketanserin competition binding (5-HT2 sites)
- Shown value from
- Glennon et al. 1984, Table 1
- Range
- 390–1200 nM in 4 reports
- Error
- ± 100 SEM
Sources and values behind the range, same assay family Report Value Where Colas et al. 1997 631 nM Table 1 Glennon 1987 1200 nM, 390 nM Table I Glennon et al. 1984 390 nM Table 1 Bufotenin398 nMColas et al. 1997
- Assay
- rat 5-HT2A receptor expressed in COS-1 cells, [125I]DOI competition binding
- Shown value from
- Colas et al. 1997, Table 1
DMT440 nMDeliganis et al. 1991
- Assay
- Rat frontal cortex membranes, [3H]ketanserin competition without GTP (5-HT2 receptor, now 5-HT2A)
- Shown value from
- Deliganis et al. 1991, Results, Fig. 1B
- Error
- ± 20 SEM, n = 3
Ibogaine4800 nMSweetnam et al. 1995
- Assay
- rat cortex, [3H]ketanserin displacement
- Shown value from
- Sweetnam et al. 1995, Table 3 (Sweetnam)
Unspecified
9 measurements
LSD5.2 nMEgan et al. 2000 · 3 reports
- Assay
- NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
- Shown value from
- Egan et al. 2000, Table I
- Range
- 2.4–5.5 nM in 3 reports
- Error
- ± 0.70 SEM, n = 3
Sources and values behind the range, same assay family Report Value Where Egan et al. 2000 5.2 nM Table I Glennon 1987 2.4 nM Text, section 5 (Ergolines) Basargin et al. 2026 5.5 nM SI Table S1, p. S18 LSA28 nMPaulke et al. 2013
- Assay
- receptor binding assay; generic 5-HT2 label in the paper; pKi converted to Ki
- Shown value from
- Paulke et al. 2013, Table 2
DOI52 nMEgan et al. 2000
- Assay
- NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
- Shown value from
- Egan et al. 2000, Table I
- Error
- ± 11 SEM, n = 3
DOB81 nMEgan et al. 2000 · 2 reports
- Assay
- NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
- Shown value from
- Egan et al. 2000, Table I
- Range
- 41–81 nM in 2 reports
- Error
- ± 20 SEM, n = 3
Sources and values behind the range, same assay family Report Value Where Egan et al. 2000 81 nM Table I Glennon 1987 41 nM Table II Bufotenin145 nMEgan et al. 2000 · 5 reports
- Assay
- NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
- Shown value from
- Egan et al. 2000, Table I
- Range
- 15–557 nM in 5 reports
- Error
- ± 8.5 SEM, n = 3
Reported values disagree and no value is established. 5 reports in all, 15–557 nM.
Sources and values behind the range, same assay family Report Value Where Chen et al. 2023 557 nM Table 2 Egan et al. 2000 145 nM Table I Glennon 1987 380 nM, 480 nM Table III Plazas et al. 2023 15 nM Table 5 DOM306 nMEgan et al. 2000 · 2 reports
- Assay
- NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
- Shown value from
- Egan et al. 2000, Table I
- Range
- 100–306 nM in 2 reports
- Error
- ± 56 SEM, n = 3
Sources and values behind the range, same assay family Report Value Where Egan et al. 2000 306 nM Table I Glennon 1987 100 nM Table II Psilocin331 nMChen et al. 2023 · 2 reports
- Assay
- 5-HT2A receptor membranes (PerkinElmer ES-313-M400UA); [3H]ketanserin scintillation proximity competition binding
- Shown value from
- Chen et al. 2023, Table 2
- Range
- 107–331 nM in 2 reports
- Error
- ± 96 SD, n = 3
Sources and values behind the range, same assay family Report Value Where Chen et al. 2023 331 nM Table 2 Dodd et al. 2023 107 nM Table 2 5-MeO-DMT1325 nMEgan et al. 2000 · 2 reports
- Assay
- NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
- Shown value from
- Egan et al. 2000, Table I
- Range
- 113–1325 nM in 2 reports
- Error
- ± 163 SEM, n = 3
Reported values disagree and no value is established. 2 reports in all, 113–1325 nM.
Sources and values behind the range, same assay family Report Value Where Chen et al. 2023 113 nM Table 2 Egan et al. 2000 1325 nM Table I DMT1513 nMChen et al. 2023 · 2 reports
- Assay
- 5-HT2A receptor membranes (PerkinElmer ES-313-M400UA); [3H]ketanserin scintillation proximity competition binding
- Shown value from
- Chen et al. 2023, Table 2
- Range
- 127–1513 nM in 2 reports
- Error
- ± 639 SD, n = 3
Sources and values behind the range, same assay family Report Value Where Chen et al. 2023 1513 nM Table 2 Keiser et al. 2009 127 nM Supplementary Table 4
Functional potency (EC₅₀)
24 substances, 38 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.
Human
24 measurements
LSD0.71 nMEshleman et al. 2018 · 2 reports
- Assay
- recombinant human 5-HT2A receptor; IP-1 formation
- Shown value from
- Eshleman et al. 2018, Table 2
- Range
- 0.24–0.71 nM in 2 reports
- Error
- ± 0.07 SEM, n = 3
- Emax
- 64.5 ± 6.3%
This is the best-supported value. Other reports differ. 14 reports in all, 0.24–260 nM.
Sources and values behind the range, same assay family Report Value Where Eshleman et al. 2018 0.71 nM Table 2 Janowsky et al. 2014 0.24 nM Table 2 DOB1.5 nMPorter et al. 1999
- Assay
- CHO-K1 cells stably expressing recombinant human 5-HT2A; FLIPR calcium mobilization
- Shown value from
- Porter et al. 1999, Table 1
- Emax
- 74.0%
This is the best-supported value. Other reports differ. 6 reports in all, 0.52–724 nM.
DOI1.8 nMElmore et al. 2018 · 3 reports
- Assay
- HEK293 human 5-HT2A calcium mobilization
- Shown value from
- Elmore et al. 2018, Table 1
- Range
- 0.90–2.4 nM in 3 reports
- Error
- ± 0.30 SEM
- Emax
- 109.0%
This is the best-supported value. Other reports differ. 8 reports in all, 0.42–295 nM.
Sources and values behind the range, same assay family Report Value Where Porter et al. 1999 0.90 nM Table 1 Jain et al. 2025 2.4 nM Table S6 Elmore et al. 2018 1.8 nM Table 1 Psilocin2.4 nMKlein et al. 2020 · 5 reports
- Assay
- Flp-In T-REx 293 cells expressing human 5-HT2A; Gq-mediated calcium flux
- Shown value from
- Klein et al. 2020, Table 3
- Range
- 2.4–721 nM in 5 reports
- Emax
- 98.4 ± 1.3%
This is the best-supported value. Other reports differ. 12 reports in all, 2.4–5080 nM.
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 721 nM Table 1 Klein et al. 2020 2.4 nM Table 3 Glatfelter et al. 2022 13 nM Table 2 Jain et al. 2025 7.6 nM Table S6 Blough et al. 2014 45 nM Table 2 Bufotenin3.5 nMBlough et al. 2014 · 2 reports
- Assay
- human 5-HT2A receptor in HEK293 cells; calcium mobilization
- Shown value from
- Blough et al. 2014, Table 1
- Range
- 3.5–4.8 nM in 2 reports
- Error
- ± 0.08 SEM, n = 3
- Emax
- 100.0 ± 2.0%
This is the best-supported value. Other reports differ. 4 reports in all, 3.5–1730 nM.
Sources and values behind the range, same assay family Report Value Where Jain et al. 2025 4.8 nM Table S6 Blough et al. 2014 3.5 nM Table 1 4-HO-MET4.0 nMKlein et al. 2020 · 3 reports
- Assay
- Flp-In T-REx 293 cells expressing human 5-HT2A; Gq-mediated calcium flux
- Shown value from
- Klein et al. 2020, Table 3
- Range
- 4.0–37 nM in 3 reports
- Emax
- 96.8 ± 1.1%
This is the best-supported value. Other reports differ. 4 reports in all, 4.0–87 nM.
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 37 nM Table 1 Klein et al. 2020 4.0 nM Table 3 Glatfelter et al. 2023 18 nM Table S1 (Supporting Information) 2C-I5.9 nMPottie et al. 2020
- Assay
- stable HEK293 5-HT2A–β-arrestin2 recruitment
- Shown value from
- Pottie et al. 2020, Table 2
- Emax
- 70.6%
Values depend on the assay, species or conditions, and each is valid only for its own. 7 reports in all, 4.0–510 nM.
2C-E6.9 nMPottie et al. 2020
- Assay
- stable HEK293 5-HT2A–β-arrestin2 recruitment
- Shown value from
- Pottie et al. 2020, Table 2
- Emax
- 83.5%
Values depend on the assay, species or conditions, and each is valid only for its own. 7 reports in all, 2.5–110 nM.
AL-LAD8.3 nMJain et al. 2025
- Assay
- 5-HT2A receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
- Shown value from
- Jain et al. 2025, Table S6
5-MeO-DMT8.9 nMGlatfelter et al. 2024 · 4 reports
- Assay
- Transfected cells expressing human 5-HT2A; Galpha-q dissociation BRET
- Shown value from
- Glatfelter et al. 2024, Figure 2A-B
- Range
- 8.9–183 nM in 4 reports
- Emax
- 95.3%
This is the best-supported value. Other reports differ. 13 reports in all, 1.9–385 nM.
Sources and values behind the range, same assay family Report Value Where Glatfelter et al. 2024 8.9 nM Figure 2A-B Ray 2010 50 nM, 57 nM, 183 nM Table S3 2C-B9.0 nMPottie et al. 2020
- Assay
- stable HEK293 5-HT2A–β-arrestin2 recruitment
- Shown value from
- Pottie et al. 2020, Table 2
- Emax
- 89.0%
Values depend on the assay, species or conditions, and each is valid only for its own. 4 reports in all, 1.9–80 nM.
ETH-LAD9.3 nMJain et al. 2025
- Assay
- 5-HT2A receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
- Shown value from
- Jain et al. 2025, Table S6
- Emax
- 94.5 ± 1.5%
5-MeO-MiPT17 nMGlatfelter et al. 2024 · 3 reports
- Assay
- Transfected cells expressing human 5-HT2A; Galpha-q dissociation BRET
- Shown value from
- Glatfelter et al. 2024, Figure 2A-B
- Range
- 17–285 nM in 3 reports
- Emax
- 94.8%
This is the best-supported value. Other reports differ. 11 reports in all, 5.9–566 nM.
Sources and values behind the range, same assay family Report Value Where Glatfelter et al. 2024 17 nM Figure 2A-B Ray 2010 20 nM, 285 nM Table S3 2C-C19 nMPottie et al. 2020
- Assay
- stable HEK293 5-HT2A–β-arrestin2 recruitment
- Shown value from
- Pottie et al. 2020, Table 2
- Emax
- 91.2%
Values depend on the assay, species or conditions, and each is valid only for its own. 5 reports in all, 4.6–200 nM.
ALD-5238 nMHalberstadt et al. 2020
- Assay
- Flp-In T-REx 293 cells expressing human 5-HT2A; Gq calcium mobilization
- Shown value from
- Halberstadt et al. 2020, Table 4
- Emax
- 25.0 ± 2.0%
DOM40 nMEshleman et al. 2018 · 3 reports
- Assay
- recombinant human 5-HT2A receptor; IP-1 formation
- Shown value from
- Eshleman et al. 2018, Table 2
- Range
- 21–40 nM in 3 reports
- Error
- ± 5.4 SEM, n = 3
- Emax
- 94.6 ± 4.1%
This is the best-supported value. Other reports differ. 14 reports in all, 2.4–1698 nM.
Sources and values behind the range, same assay family Report Value Where Luethi et al. 2026 21 nM Table 1 Eshleman et al. 2018 40 nM Table 2 Janowsky et al. 2014 25 nM Table 2 2C-D44 nMPottie et al. 2020 · 2 reports
- Assay
- stable HEK293 5-HT2A–β-arrestin2 recruitment
- Shown value from
- Pottie et al. 2020, Table 2
- Range
- 16–44 nM in 2 reports
- Emax
- 78.7%
Values depend on the assay, species or conditions, and each is valid only for its own. 8 reports in all, 16–8100 nM.
Sources and values behind the range, same assay family Report Value Where Pottie et al. 2020 44 nM Table 2 Pottie et al. 2023 16 nM Table 1 2C-P90 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A (functional FLIPR membrane potential)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 60 SD
- Emax
- 63.0 ± 5.0%
DMT527 nMKozell et al. 2023 · 3 reports
- Assay
- human 5-HT2A receptor in HEK-293 cells; IP-1 formation (Cisbio kit)
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 227–527 nM in 3 reports
- Error
- ± 45 SEM, n = 20
- Emax
- 38.4 ± 1.8%
Reported values disagree and no value is established. 14 reports in all, 38–871 nM.
Sources and values behind the range, same assay family Report Value Where Kozell et al. 2023 527 nM Table 1 Janowsky et al. 2014 227 nM Table 2 Cameron et al. 2018 269 nM Table 2 MDA630 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A receptor, functional activation
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 240 SD
- Emax
- 77.0 ± 16.0%
Psilocybin1242 nMGlatfelter et al. 2022
- Assay
- cells expressing human 5-HT2A; beta-arrestin 2 recruitment
- Shown value from
- Glatfelter et al. 2022, Table 2
- Emax
- 74.0%
Values depend on the assay, species or conditions, and each is valid only for its own. 4 reports in all, 1242–4900 nM.
MDMA5200 nMJain et al. 2025
- Assay
- 5-HT2A receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
- Shown value from
- Jain et al. 2025, Table S6
- Emax
- 46.9 ± 2.3%
6-APB5900 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A receptor, functional activation
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 1800 SD
- Emax
- 43.0 ± 23.0%
5-APB6300 nMRickli et al. 2015
- Assay
- cloned human 5-HT2A receptor, functional activation
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 2100 SD
- Emax
- 54.0 ± 35.0%
Mouse
6 measurements
4-HO-MET2.5 nMKlein et al. 2020
- Assay
- Flp-In T-REx 293 cells expressing mouse 5-HT2A; Gq-mediated calcium flux
- Shown value from
- Klein et al. 2020, Table 3
- Emax
- 98.2 ± 1.2%
Psilocin3.2 nMKlein et al. 2020
- Assay
- Flp-In T-REx 293 cells expressing mouse 5-HT2A; Gq-mediated calcium flux
- Shown value from
- Klein et al. 2020, Table 3
- Emax
- 95.7 ± 1.0%
LSD4.3 nMHalberstadt et al. 2020
- Assay
- Flp-In T-REx 293 cells expressing mouse 5-HT2A; Gq calcium mobilization
- Shown value from
- Halberstadt et al. 2020, Table 4
- Emax
- 86.0 ± 3.0%
ALD-5212 nMHalberstadt et al. 2020
- Assay
- Flp-In T-REx 293 cells expressing mouse 5-HT2A; Gq calcium mobilization
- Shown value from
- Halberstadt et al. 2020, Table 4
- Emax
- 29.0 ± 1.0%
5-MeO-DMT48 nMGlatfelter et al. 2024
- Assay
- Transfected cells expressing mouse 5-HT2A; Galpha-q dissociation BRET
- Shown value from
- Glatfelter et al. 2024, Figure 2A-B
- Emax
- 91.6%
5-MeO-MiPT50 nMGlatfelter et al. 2024
- Assay
- Transfected cells expressing mouse 5-HT2A; Galpha-q dissociation BRET
- Shown value from
- Glatfelter et al. 2024, Figure 2A-B
- Emax
- 96.4%
Rat
7 measurements
2C-I26 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 6.0 SEM, n = 6
- Emax
- 17.0 ± 4.0%
DOM29 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 9.0 SEM, n = 6
- Emax
- 44.0 ± 11.0%
DOB50 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 15 SEM, n = 7
- Emax
- 57.0 ± 11.0%
DOI57 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 24 SEM, n = 6
- Emax
- 46.0 ± 9.0%
2C-D586 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 312 SEM, n = 5
- Emax
- 6.0 ± 3.0%
2C-B689 nMAcuña-Castillo et al. 2002
- Assay
- rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
- Shown value from
- Acuña-Castillo et al. 2002, Table 3
- Error
- ± 179 SEM, n = 4
- Emax
- 4.0 ± 2.0%
Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 27–689 nM.
DMT3000 nMDeliganis et al. 1991
- Assay
- Rat cortical slices, phosphoinositide turnover (5-HT2 receptor, now 5-HT2A)
- Shown value from
- Deliganis et al. 1991, Results, Fig. 3
- Emax
- 20.0%
Unspecified
1 measurement
DMT983 nMSmith et al. 1998 · 2 reports
- Assay
- NIH 3T3 fibroblasts expressing the 5-HT2A receptor, [3H]inositol phosphate formation
- Shown value from
- Smith et al. 1998, Results, Fig. 1
- Emax
- 90.0%
Sources and values behind the range, same assay family Report Value Where Cameron et al. 2018 983 nM Table 2 Smith et al. 1998 983 nM Results, Fig. 1
Also reported to act here
Substances reported to act here, without a displayed value.
Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.